United States · Platforms & data · MarketBeat

Immunocore (NASDAQ:IMCR) Earns Buy Rating from HC Wainwright

Published by MarketBeat · United States 55 min ago

HC Wainwright reiterated a "buy" rating and issued a $100.00 price target on shares of Immunocore in a research note on Monday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seagate Technology Q1 preview: Analysts project earnings beat amid strong HDD demand

The Motley Fool

CEMEX (CX) Q3 2026 Earnings Call Transcript

Is it curtains for COLA? Saving Social Security could mean changing the cost-of-living adjustment.

Cadence unveils suite of AI models that chipmakers can run in-house

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Love Musk or Hate Him, Here’s How I’m Building My SpaceX Position